BamSEC and AlphaSense Join Forces
Learn More

Verrica Pharmaceuticals Inc. – Material Contracts

NASDAQ: VRCA    
Share price (6/2/26): $5.79    
Market cap (6/2/26): $99.5 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.31
from 10-K 6 pages Material contract
12/34/56
EX-10.3
from 8-K 22 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 41 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 44 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 10-Q 11 pages Recitals Agreement
12/34/56
EX-10.2
from 10-Q 8 pages Material contract
12/34/56
EX-10.1
from 8-K 4 pages Release Agreement
12/34/56
EX-10.2
from 8-K 2 pages Amendment to Verrica Pharmaceuticals Inc. 2024 Inducement Plan
12/34/56
EX-10.1
from 8-K 5 pages December 5, 2024 David Zawitz Re: Employment Terms Dear David: Verrica Pharmaceuticals, Inc. (The “Company”) Is Pleased to Offer You Employment Beginning on December 9, 2024 or Such Other Date as Set by the Company in Its Discretion (The “Start Date”). Position
12/34/56
EX-10.2
from 10-Q 19 pages Release Agreement
12/34/56
EX-10.6
from 8-K 11 pages Verrica Pharmaceuticals Inc. Stock Option Grant Notice
12/34/56
EX-10.5
from 8-K 10 pages Verrica Pharmaceuticals Inc. Restricted Stock Unit Grant Notice
12/34/56
EX-10.4
from 8-K 18 pages Verrica Pharmaceuticals Inc. 2024 Inducement Plan Adopted by the Board of Directors: November 1, 2024
12/34/56
EX-10.3
from 8-K 15 pages Professional Services Agreement
12/34/56
EX-10.2
from 8-K 5 pages November 4, 2024 Jayson Rieger Re: Employment Terms Dear Jayson: Verrica Pharmaceuticals, Inc. (The “Company”) Is Pleased to Offer You Employment Beginning on November 5, 2024 or Such Other Date as Set by the Company in Its Discretion (The “Start Date”). Position; Board Role
12/34/56
EX-10.1
from 8-K 5 pages Release Agreement
12/34/56
EX-10.4
from 10-Q 10 pages First Amendment to the Collaboration and License Agreement
12/34/56
EX-10.21
from 10-K 3 pages Verrica Pharmaceuticals Inc. Second Amended and Restated Non-Employee Director Compensation Policy as Adopted by the Board on February 27, 2024
12/34/56
EX-10.3
from 10-Q 25 pages Warrant Certificate
12/34/56
EX-10.2
from 10-Q 32 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential. Omissions Are Designated [***]. Pledge and Security Agreement
12/34/56